Mary B. Daly - Concepedia

Author

Mary B. Daly

Also Known As

Ana Osorio, Chenevix-Trench, Georgia, Czene, Kamila, Daly, Mary, Daly, Mary B, Daly, Mary B., Esther M. John, Johnathan Lancaster, Kamila Czene, MARY DALY

136

Publications

9.2K

Citations

H-Index

Concepts

All Affiliations

Fox Chase Cancer Center Dana-Farber Cancer Institute University of Pennsylvania University of Chicago Creighton University

About

Mary B. Daly is an author at Fox Chase Cancer Center specializing in medicine, oncology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	2.6K
2	Public Health	7	7	1.6K
3	Social Sciences	2	2	30
4	Engineering	1	1	71
5	Biostatistics	1	1	19

Mary B. Daly

Publications

7.8K

Citations

H-Index

Page 1

	Year	Citations
Prophylactic Oophorectomy in Carriers of<i>BRCA1</i>or<i>BRCA2</i>Mutations Timothy R. Rebbeck, Henry T. Lynch, Susan L. Neuhausen, New England Journal of Medicine	2002	1.5K
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study Group Timothy R. Rebbeck, Tara M. Friebel, Henry T. Lynch, Journal of Clinical Oncology	2004	1.1K
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology Mary B. Daly, Tuya Pal, Michael P. Berry, Journal of the National Comprehensive Cancer Network Family MedicineBreast OncologyEpidemiology Of CancerGenetic EpidemiologyGynecology	2021	1.1K
Genetic/Familial High-Risk Assessment: Breast and Ovarian Mary B. Daly, Jennifer E. Axilbund, Saundra S. Buys, Journal of the National Comprehensive Cancer Network	2010	649
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study Group Timothy R. Rebbeck, Tara M. Friebel, Theresa Wagner, Journal of Clinical Oncology	2005	402
BRCA2 germline mutations in male breast cancer cases and breast cancer families Fergus J. Couch, Linda M. Farid, Michelle L. DeShano, Nature Genetics Breast OncologySomatic VariantGeneticsBreast Cancer FamiliesPathology	1996	361
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study Susan M. Domchek, Tara M. Friebel, Susan L. Neuhausen, The Lancet Oncology Surgical OncologyOphthalmologyMedicineBilateral Salpingo-oophorectomySurgery	2006	326
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019 Veda N. Giri, Karen E. Knudsen, William Kevin Kelly, Journal of Clinical Oncology	2020	273
Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG Repeat Timothy R. Rebbeck, Philip W. Kantoff, Krishna Krithivas, The American Journal of Human Genetics	1999	255
Tamoxifen and contralateral breast cancer in <i>BRCA1</i> and <i>BRCA2</i> carriers: An update Jacek Gronwald, Nadine Tung, William D. Foulkes, International Journal of Cancer	2005	251

Page 1